Drug
Pf-03882845 clinical trials
Also written PF-03882845.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
- PF-03882845
- 2
Studies by the year they started
4 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2011 | 3 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pf-03882845 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic NephropathyTerminatedPhase 1PfizerNCT01488877Written as PF-03882845
- Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin PharmacokineticsCompletedPhase 1PfizerNCT01445860Written as Simvastatin/PF-03882845
- A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy VolunteersCompletedPhase 1PfizerNCT01314898Written as 3 mg PF-03882845
- A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its AbsorptionCompletedPhase 1PfizerNCT01366287Written as PF-03882845
Codes
What other systems call pf-03882845 · ClinicalTrials.gg INT005701
- UNII (FDA) 34ZKU73FU3PF-03882845Confirmed NLM, Wikidata
- Wikidata Q27088312pf-03882845Confirmed NLM, Wikidata
- DrugBank DB11814One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 34ZKU73FU3 | PF-03882845 | Confirmed NLM, Wikidata |
| Wikidata | Q27088312 | pf-03882845 | Confirmed NLM, Wikidata |
| DrugBank | DB11814 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.